StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.48−0.14 (-8.64%)

Close on Nov 16, 2026Market cap $55.39MP/E –Yield –

Tenax Therapeutics cash

Cash and short-term investments held at the end of each period.

Tenax Therapeutics's cash was $118.00M at Jun 30, 2026. For fiscal 2025 it was $97.57M, up 2.9% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $97.57M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$97.57M+2.9%
FY2024Dec 31, 2024$94.85M+868.7%
FY2023Dec 31, 2023$9.79M+361.0%
FY2022Dec 31, 2022$2.12M-62.0%
FY2021Dec 31, 2021$5.58M-16.8%
FY2020Dec 31, 2020$6.71M+24.3%
FY2019Dec 31, 2019$5.40M-58.0%
FY2018Dec 31, 2018$12.86M+66.5%
FY2017Dec 31, 2017$7.73M-54.9%
FY2015Apr 30, 2015$17.13M-70.6%
FY2014Apr 30, 2014$58.32M+7343.3%
FY2013Apr 30, 2013$783.53K-58.3%
FY2012Apr 30, 2012$1.88M+97.5%
FY2011Apr 30, 2011$951.94K+50.5%
FY2010Apr 30, 2010$632.71K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$118.00M+11.9%
Q1 FY2026CQ1 2026Mar 31, 2026$118.80M+6.6%
Q4 FY2025CQ4 2025Dec 31, 2025$97.57M+2.9%
Q3 FY2025CQ3 2025Sep 30, 2025$99.40M+1.1%
Q2 FY2025CQ2 2025Jun 30, 2025$105.46M+1023.8%
Q1 FY2025CQ1 2025Mar 31, 2025$111.45M+788.1%
Q4 FY2024CQ4 2024Dec 31, 2024$94.85M+868.7%
Q3 FY2024CQ3 2024Sep 30, 2024$98.31M+782.4%
Q2 FY2024CQ2 2024Jun 30, 2024$9.38M-29.9%
Q1 FY2024CQ1 2024Mar 31, 2024$12.55M-12.9%
Q4 FY2023CQ4 2023Dec 31, 2023$9.79M+361.0%
Q3 FY2023CQ3 2023Sep 30, 2023$11.14M+192.7%
Q2 FY2023CQ2 2023Jun 30, 2023$13.39M+85.3%
Q1 FY2023CQ1 2023Mar 31, 2023$14.41M+402.5%
Q4 FY2022CQ4 2022Dec 31, 2022$2.12M-62.0%
Q3 FY2022CQ3 2022Sep 30, 2022$3.81M-54.4%
Q2 FY2022CQ2 2022Jun 30, 2022$7.23M+231.3%
Q1 FY2022CQ1 2022Mar 31, 2022$2.87M-28.8%
Q4 FY2021CQ4 2021Dec 31, 2021$5.58M-16.8%
Q3 FY2021CQ3 2021Sep 30, 2021$8.35M-4.1%
Q2 FY2021CQ2 2021Jun 30, 2021$2.18M-52.1%
Q1 FY2021CQ1 2021Mar 31, 2021$4.03M-17.0%
Q4 FY2020CQ4 2020Dec 31, 2020$6.71M+24.3%
Q3 FY2020CQ3 2020Sep 30, 2020$8.71M+22.2%
Q2 FY2020CQ2 2020Jun 30, 2020$4.55M-48.9%
Q1 FY2020CQ1 2020Mar 31, 2020$4.86M-55.1%
Q4 FY2019CQ4 2019Dec 31, 2019$5.40M-58.0%
Q3 FY2019CQ3 2019Sep 30, 2019$7.13M+46.8%
Q2 FY2019CQ2 2019Jun 30, 2019$8.91M+39.1%
Q1 FY2019CQ1 2019Mar 31, 2019$10.82M+63.6%
Q4 FY2018CQ4 2018Dec 31, 2018$12.86M+66.5%
Q3 FY2018CQ3 2018Sep 30, 2018$4.86M-43.1%
Q2 FY2018CQ2 2018Jun 30, 2018$6.41M-27.2%
Q1 FY2018CQ1 2018Mar 31, 2018$6.62M-47.2%
Q4 FY2017CQ4 2017Dec 31, 2017$7.73M-54.9%
Q3 FY2017CQ3 2017Sep 30, 2017$8.53M-50.0%
Q2 FY2017CQ2 2017Jun 30, 2017$8.80M–
Q1 FY2017CQ1 2017Mar 31, 2017$12.52M–
Q4 FY2015CQ1 2015Apr 30, 2015$17.13M–
Q3 FY2015CQ4 2014Jan 31, 2015$17.07M–

More Tenax Therapeutics figures

See a number that looks wrong?